default author photo

Tarsizio Chikaonda

University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme

P.O. Box 30096, Chichiri

Blantyre 3, Malawi

Blantyre

Malawi

SCHOLARLY PAPERS

4

DOWNLOADS

279

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Long-Term Protective Effect of 13-Valent Pneumococcal Conjugate Vaccine Against Experimental Carriage Determined by Re-Challenge with Streptococcus Pneumoniae Serotype 6b in Blantyre, Malawi

Number of pages: 19 Posted: 13 Dec 2024
Anthony Emeritus Chirwa, Evaristar Kudowa, Godwin Tembo, Ben Morton, Dingase Dula, Simon Sichone, Bridgette Galafa, Faith Thole, Christopher Mkandawire, Lumbani Makhaza, Edna Nsomba, Vitumbiko Nkhoma, Edward Mangani, Mphatso Mailboy, Shalom Songolo, Clara Ngoliwa, Linda Chamtunga, Modesta Reuben, Chikondi Chakwiya, Pemphero Liwonde, Mphatso Chaponda, Neema Toto, Ralphael Kamng'ona, Alfred Muyaya, Lorensio Chimgoneko, Morrison P. Kamanga, John Ndaferankhande, Gift Chiwala, Ndaziona Peter Kwanjo Banda, Marc YR Henrion, Daniela M. Ferreira, Tarsizio Chikaonda, Kondwani Jambo, Stephen B. Gordon and Malawi Accelerated Research in Vaccines Experimental and Laboratory Systems (MARVELS) Consortium
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Liverpool School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Liverpool School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme and Independent
Downloads 113 (626,371)

Abstract:

Loading...

Streptococcus pneumoniae, Controlled Human Infection Model, Experimental pneumococcal carriage, challenge, re-challenge, Pneumococcal Conjugate Vaccine, Randomised Controlled Trial, Malawi

2.

Randomised Controlled Trial of Pneumococcal Conjugate Vaccine Shows Protection Against Experimental Pneumococcal Carriage in First Human Infection Study in Africa

Number of pages: 30 Posted: 15 Dec 2022
Dingase Dula, Ben Morton, Tarsizio Chikaonda, Anthony Emeritus Chirwa, Edna Nsomba, Vitumbiko Nkhoma, Clara Ngoliwa, Simon Sichone, Bridgette Galafa, Godwin Tembo, Mphatso Chaponda, Neema Toto, Ralphael Kamng'ona, Lumbani Makhaza, Alfred Muyaya, John Ndaferankhande, Christopher Mkandawire, Lorensio Chimgoneko, Ndaziona Peter Kwanjo Banda, Jamie Rylance, Evaristar Kudowa, Ashleigh Howard, Tinashe Kenny Nyazika, Daniela M. Ferreira, Kondwani Jambo, Marc YR Henrion and Stephen B. Gordon
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Liverpool - School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 82 (790,029)

Abstract:

Loading...

Streptococcus pneumoniae, controlled Human infection Model, Pneumococcal carriage, Nasal, Mucosal inflammation, Malawi

3.

Whole Cell Inactivated Poly-Bacterial Preparation MV130 Effect on Nasal Mucosal Immunity and Experimental Human Pneumococcal Carriage: Double-Blind Randomized Controlled Trial with Controlled Human Infection Model ​

Number of pages: 29 Posted: 17 Mar 2026
John Ndaferankhande, Kondwani Jambo, Tarsizio Chikaonda, Godwin Tembo, Laura Conejero, Marc YR Henrion, Evaristar Kudowa, Gareth Lipunga, Anthony Emeritus Chirwa, Edna Nsomba, Mphatso Chaponda, Mphatso Mailboy, Andrew Sigoloti, Shalom Songolo, Neema Toto, Faith Thole, Ndaziona Peter Banda, Bridgette Galafa, Glory Kadzanja, Morrison P. Kamanga, Lorensio Chimgoneko, Tiyamika Nthandira, Benson M. Tembo, Alfred Muyaya, Lumbani Makhaza, Bright Lipenga, Vusumuzi Katangwe, Gift Chiwala, Jonathan Grigg and Stephen B. Gordon
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Immunotek, S.L., University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Queen Mary University of London and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 47 (1,097,529)

Abstract:

Loading...

trained immunity, vaccine, CHIM, mucosal immunity, Streptococcus pneumoniae

4.

Controlled Human Infection Model (CHIM) inoculum production in Malawi using principles of Good Manufacturing Practice

Number of pages: 21 Posted: 29 Aug 2025
Tarsizio Chikaonda, Glory Kadzanja, Belson Kutambe, Mavis Menyere, Faith Thole, Phillip M. Ashton, Daniela M. Ferreira, Ashleigh Howard, Kondwani Jambo, Stephen B. Gordon, Bridgette Galafa and Morrison P. Kamanga
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, affiliation not provided to SSRN, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 37 (1,222,651)

Abstract:

Loading...

Principles of GMP, Pneumococcal carriage, Streptococcus pneumoniae, Experimental Human Pneumococcal Challenge, Controlled Human Infection Model